Elite Pharmaceuticals Inc (ELTP)

[RizZo]

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2021 Results on August 17, 2020

Published: Aug 12, 2020

NORTHVALE, NJ / ACCESSWIRE / August 12, 2020 / Elite Pharmaceuticals, Inc., ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will release its 2021 first quarter financial results on Friday, August 14, 2020. Elite's management will host a live conference call Monday, August 17 at 11:30 AM EDT to discuss the company's financial and operating results and provide a general business update. Stockholders may submit questions to the company prior to the call.

Conference Call Information

Date:

August 17, 2020

Time:

11:30 AM EDT

Dial- in numbers:

1-800-346-7359 (domestic)
1-973-528-0008 (international)

Conference number:

98840


Audio Replay:

https://elite.irpass.com/events_presentations

About Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to TAGI Pharma, Glenmark Pharmaceuticals, Inc., USA, and Lannett Company, Inc. Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ.


https://www.biospace.com/article/elite-pharmaceuticals-inc-to-host-conference-call-to-provide-corporate-update-and-discuss-first-quarter-of-fiscal-year-2021-results-on-august-17-2020/